BARDA within the Office of the Assistant Secretary for Preparedness and Response in the U.S. Department of Health and Human Services.
Business Model: Goverment
Revenue: $0
Employees: 201-500
Address:
City: Washington
State: District of Columbia
Zip:
Country: United States
The Biomedical Advanced Research and Development Authority (BARDA), within the Office of the Assistant Secretary for Preparedness and Response in the U.S. Department of Health and Human Services, provides an integrated, systematic approach to the development and purchase of the necessary vaccines, drugs, therapies, and diagnostic tools for public health medical emergencies.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
7/2019 | Integrated BioTherapeutics | Grant | 1.6M |
2/2021 | Visby Medical | Grant | 12.3M |
9/2008 | SIGA Technologies | Grant | 55M |
8/2022 | Spectral MD | Grant | 8.2M |
9/2021 | Spectral MD | Grant | 18.8M |
3/2022 | The Stevanato Group | Grant | 95M |
10/2020 | First Light Diagnostics | Grant | 4M |
4/2020 | Cue | Grant | 13M |
9/2014 | Spectral MD | Grant | 26M |
1/2022 | Cue | Grant | - |
3/2020 | MediWound | Grant | 5.5M |
6/2016 | Terumo | Grant | 17.4M |
6/2020 | QuidelOrtho | Grant | - |
6/2020 | Corning | Grant | 204M |
9/2022 | Sabin Vaccine Institute | Grant | 21.8M |
6/2021 | SeLux Diagnostics | Grant | 14.6M |
4/2020 | Paratek Pharmaceuticals | Post-IPO Equity | - |
8/2019 | Altimmune | Grant | 3.7M |
4/2020 | Emergent BioSolutions | Grant | 14.5M |
9/2016 | Moderna Therapeutics | Grant | 8M |
8/2022 | Everglade Consulting | Grant | 39M |
10/2020 | Vaxxas | Grant | 22M |
7/2019 | Spectral MD | Grant | 27.3M |
12/2019 | First Light Diagnostics | Grant | 4.3M |
4/2020 | Moderna Therapeutics | Grant | 483M |
8/2022 | Arcturus Therapeutics | Grant | 63.2M |
9/2022 | Enalare Therapeutics | Grant | 50.3M |
3/2020 | GenMark Diagnostic | Grant | - |
5/2022 | BugSeq Bioinformatics | Grant | - |
1/2020 | Summit Therapeutics | Post-IPO Equity | 8.8M |
4/2021 | Spectral MD | Grant | 20.6M |
7/2020 | Moderna Therapeutics | Grant | 472M |
7/2016 | Soligenix | Grant | 634k |
4/2020 | Vela Diagnostics Pte. Ltd. | Grant | 225k |
8/2021 | Basilea Pharmaceutica | Grant | 4.3M |
4/2020 | SeLux Diagnostics | Grant | 9.6M |
7/2022 | SeLux Diagnostics | Unattributed | 8M |
1/2022 | Spero Therapeutics | Grant | 12.9M |
8/2018 | Summit Therapeutics | Post-IPO Equity | 2M |
1/2022 | Opiant Pharmaceuticals | Grant | 2M |
9/2022 | T2 Biosystems | Grant | 3.7M |
9/2019 | T2 Biosystems | Grant | 69M |
9/2017 | Velico Medical | Venture Round | 19M |
9/2019 | BioFactura | Grant | 67.4M |
12/2019 | Qpex Biopharma | Grant | 20M |
4/2020 | RxSight | Venture Round | 9.6M |
7/2021 | Cepheid | Grant | 27M |
9/2020 | Vedanta Biosciences | Grant | 76.9M |
10/2022 | OraSure Technologies | Grant | 10.4M |
9/2016 | Sanofi Pasteur | Grant | 43.2M |
3/2022 | Visby Medical | Grant | 25.5M |
1/2023 | Sabin Vaccine Institute | Grant | 35M |
7/2022 | SeLux Diagnostics | Grant | 0 |
5/2022 | BugSeq Bioinformatics | Grant | - |
3/2022 | Visby Medical | Grant | 0 |
3/2022 | The Stevanato Group | Grant | 0 |
1/2022 | Opiant Pharmaceuticals | Grant | 0 |
1/2022 | Spero Therapeutics | Grant | 0 |
1/2022 | Cue | Grant | - |
9/2021 | Spectral MD | Grant | 0 |
8/2021 | Basilea Pharmaceutica | Grant | 0 |
7/2021 | Cepheid | Grant | 0 |
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|